Recent reports have indicated that combining p16 immunostaining with MDM2 and CDK4 improves the accuracy of the differential diagnosis of atypical lipomatous tumors/WDLPS and DDLPS. Here, MDM2 is linked to dedifferentiated liposarcoma.